Finance

Lists
Why is 301211 down 2.60%?
Dive Deeper
301211:SHE
Hubei Biocause Heilen Pharmacetcl Co Ltd
CN¥12.37
-2.60%
(-0.33) 1D
Oct 8, 3:04:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301211...
Open
CN¥12.75
High
CN¥13.13
Low
CN¥12.27
Mkt. cap
5.30B
Avg. vol.
16.99M
Volume
16.50M
Dividend
0.49%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 12, 2026
P/E ratio
116.15
52-wk high
CN¥16.95
52-wk low
CN¥9.01
EPS
CN¥0.11
Shares outstanding
417.60M
No. of employees
952
Open
CN¥12.75
High
CN¥13.13
Low
CN¥12.27
Mkt. cap
5.30B
Avg. vol.
16.99M
Volume
16.50M
Dividend
0.49%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 12, 2026
P/E ratio
116.15
52-wk high
CN¥16.95
52-wk low
CN¥9.01
EPS
CN¥0.11
Shares outstanding
417.60M
No. of employees
952
News stories
From web sources and news partners
About Hubei Biocause Heilen Pharmacetcl Co Ltd
CEO-
Employees952
FoundedDec 29, 1995
Headquarters-
SectorPharmaceutical industry
Websitebiocause.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
84.13M
134.41M
120.16M
127.35M
Cost of goods sold
67.40M
105.00M
95.02M
94.95M
Cost of revenue
67.40M
105.00M
95.02M
94.95M
Research and development expenses
4.95M
4.98M
5.50M
7.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.92M
15.28M
16.59M
17.33M
Operating expense
20.75M
25.30M
22.32M
25.52M
Total operating expenses
88.15M
130.30M
117.33M
120.47M
Operating income
-4.02M
4.11M
2.83M
6.88M
Other non operating income
-583.14K
403.42K
-1.74M
1.79M
EBT including unusual items
2.60M
18.14M
10.25M
23.14M
EBT excluding unusual items
-1.30M
17.18M
2.34M
8.78M
Income tax expense
208.89K
4.17M
1.03M
2.22M
Effective tax rate
8.05%
22.97%
10.07%
9.61%
Other operating expenses
-135.10K
4.52M
-146.78K
1.55M
Net income
2.39M
13.98M
9.22M
20.92M
Net profit margin
2.84%
10.40%
7.67%
16.43%
Earnings per share
-
-
-
-
Interest and investment income
3.37M
14.26M
1.28M
3.31M
Interest expense
-35.60K
-44.85K
-27.99K
-23.93K
Net interest expenses
3.34M
14.22M
1.25M
3.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.99M
14.66M
13.38M
18.87M
Gain or loss from assets sale
11.87K
-11.87K
-
-4.59K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps